SCHEMBL15096072

SCHEMBL15096072

COC(C(O)CO)C(O)C(O)C(O)CO

nearest known ligand 0.55

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
TDP1 Q9NUW8 2/20 0.52
KDM4E B2RXH2 2/20 0.44
MGAM O43451 2/20 0.41
SI P14410 1/20 0.41
PDE4A P27815 1/20 0.39
USP2 O75604 1/20 0.37
SLCO1B1 Q9Y6L6 1/20 0.37
TOP1 P11387 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19741471 0.92 LMNA (0.50) LMNAL3MBTL1TDP1KDM4EMGAM
SCHEMBL19741472 0.92 LMNA (0.50) LMNAL3MBTL1TDP1KDM4EMGAM
SCHEMBL11146422 0.92 LMNA (0.50) LMNAL3MBTL1TDP1KDM4EMGAM
SCHEMBL6696405 0.92 LMNA (0.50) LMNAL3MBTL1TDP1KDM4EMGAM
SCHEMBL11145479 0.84 LMNA (0.42) LMNAL3MBTL1TDP1KDM4EMGAM
SCHEMBL14554334 0.84 LMNA (0.42) LMNAL3MBTL1TDP1KDM4EMGAM
SCHEMBL1780664 0.84 LMNA (0.42) LMNAL3MBTL1TDP1KDM4EMGAM
SCHEMBL9246336 0.84 LMNA (0.42) LMNAL3MBTL1TDP1KDM4EMGAM
SCHEMBL12330492 0.84 LMNA (0.42) LMNAL3MBTL1TDP1KDM4EMGAM
SCHEMBL17168358 0.84 LMNA (0.42) LMNAL3MBTL1TDP1KDM4EMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170218129-A1 METHOD FOR PRODUCING LIQUID HIGH-PURITY SUGAR DERIVATIVE-MODIFIED SILICONE OR COMPOSITION THEREOF DOW TORAY CO., LTD. (JP) 2017-08-03 US disclosed
US-9480630-B2 Co-modified organopolysiloxane, emulsifier for water-in-oil emulsion, external use preparation, and cosmetic composition using the same DOW CORNING TORAY CO., LTD. (JP) 2016-11-01 US disclosed
US-9475828-B2 Organopolysiloxane and use thereof as surfactant, powder treatment agent, thickening agent of oil-based raw material or gelling agent. gel and emulsion compositions, as well as, preparations for external use and cosmetics comprising the same DOW CORNING TORAY CO., LTD. (JP) 2016-10-25 US disclosed
US-20150011656-A1 Co-Modified Organopolysiloxane, Emulsifier For Water-In-Oil Emulsion, External Use Preparation, And Cosmetic Composition Using The Same DOW TORAY CO., LTD. (JP) 2015-01-08 US disclosed
US-20140193353-A1 Novel Organopolysiloxane Elastomer And Use Therefor DOW CORNING TORAY CO. LTD. (JP) 2014-07-10 US disclosed
US-20140187649-A1 Novel Liquid Organo Polysiloxane And Use Therefor Dow Coming Toray Co., Ltd (JP) 2014-07-03 US disclosed
US-20130210930-A1 ORGANOPOLYSILOXANE AND USE THEREOF AS SURFACTANT, POWDER TREATMENT AGENT, THICKENING AGENT OF OIL-BASED RAW MATERIAL OR GELLING AGENT. GEL AND EMULSION COMPOSITIONS, AS WELL AS, PREPARATIONS FOR EXTERNAL USE AND COSMETICS COMPRISING THE SAME DOW CORNING TORAY CO., LTD. (JP) 2013-08-15 US disclosed
US-20130177516-A1 Cosmetic For Hair Containing Sugar Alcohol-Modified Silicone DOW CORNING TORAY CO., LTD. (JP) 2013-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150011656-A1 Co-Modified Organopolysiloxane, Emulsifier For Water-In-Oil Emulsion, External Use Preparation, And Cosmetic Composition Using The Same H1-10, F12, H1-0 LMNA 3366/4885L3MBTL1 3374/4885TDP1 3688/4885
US-20170218129-A1 METHOD FOR PRODUCING LIQUID HIGH-PURITY SUGAR DERIVATIVE-MODIFIED SILICONE OR COMPOSITION THEREOF SORD, GYS1, CD44 LMNA 954/4885L3MBTL1 1486/4885TDP1 2988/4885
US-20130210930-A1 ORGANOPOLYSILOXANE AND USE THEREOF AS SURFACTANT, POWDER TREATMENT AGENT, THICKENING AGENT OF OIL-BASED RAW MATERIAL OR GELLING AGENT. GEL AND EMULSION COMPOSITIONS, AS WELL AS, PREPARATIONS FOR EXTERNAL USE AND COSMETICS COMPRISING THE SAME DDOST, RPN1, RPN2 LMNA 633/4885L3MBTL1 3339/4885TDP1 4326/4885
US-20140187649-A1 Novel Liquid Organo Polysiloxane And Use Therefor OR51E2, SORD, CUTA LMNA 4007/4885L3MBTL1 2133/4885TDP1 3790/4885
US-20130177516-A1 Cosmetic For Hair Containing Sugar Alcohol-Modified Silicone DPM1, FSCN1, CD44 LMNA 873/4885L3MBTL1 4246/4885TDP1 4738/4885
US-20140193353-A1 Novel Organopolysiloxane Elastomer And Use Therefor OR51E2, SOST, ELAVL1 LMNA 3652/4885L3MBTL1 1162/4885TDP1 3882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.